Momenta Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Momenta Pharmaceuticals Inc.

MNTA 52.48

0.0%

Oct 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: IRWIN JAMES FRANKEL who wrote (2724)	1/25/2011 4:45:58 PM
From: Biomaven	Read Replies (2) of 3027

>>place probability of TEVA launching if approved? Also very high. Teva is not afraid of at-risk launches, and MNTA's argument might prove quite difficult as it raises complex issues. For example, it's quite possible that Teva "infringed" during their development process (outside the US), but are no longer infringing during the manufacturing and quality control process. Teva likely has the best pharmaceutical patent-law talent in the world - that's how they make their living. I have no idea how a case might be decided at the end of the day, but I do know that such a decision would be many years away. Turning to a valuation issue - if you were to assume Teva gets approval say 4 months from now (which is likely best case for them), about how much cash per share would MNTA have at that point? Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next